| scholarly article | Q13442814 |
| P50 | author | Hirotake Kasuga | Q57559963 |
| Hideki Ishii | Q79526722 | ||
| P2093 | author name string | Hiroshi Takahashi | |
| Toyoaki Murohara | |||
| Yukio Yuzawa | |||
| Seiichi Matsuo | |||
| Akihiko Taguchi | |||
| Shoichi Maruyama | |||
| Hirohisa Kawahara | |||
| Takanobu Toriyama | |||
| Kaoru Yasuda | |||
| Yasuhiko Ito | |||
| Akie Kikuchi-Taura | |||
| Yoshitaka Kumada | |||
| Shigejiro Iwashima | |||
| Toshihiro Soma | |||
| Takenori Ozaki | |||
| P2860 | cites work | Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 |
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Angiogenesis in health and disease | Q29614541 | ||
| Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation | Q31904935 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Circulating endothelial cells are associated with future vascular events in hemodialysis patients. | Q40447600 | ||
| Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients | Q45220147 | ||
| Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients | Q46870675 | ||
| Circulating CD34-positive cells provide an index of cerebrovascular function | Q47377874 | ||
| Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure | Q47449596 | ||
| History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients | Q53659424 | ||
| Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients | Q57623294 | ||
| Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner | Q61942737 | ||
| The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering | Q71558484 | ||
| Dialysis Therapy | Q74527974 | ||
| Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial | Q74811727 | ||
| Circulating endothelial progenitor cells are reduced in hemodialysis patients | Q79272284 | ||
| Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk | Q80121226 | ||
| Uremia causes endothelial progenitor cell deficiency | Q80340631 | ||
| Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment | Q80761845 | ||
| Circulating CD34-positive cell number is associated with brain natriuretic peptide level in type 2 diabetic patients | Q81498119 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemodialysis patient | Q126109077 |
| P304 | page(s) | 1603-1609 | |
| P577 | publication date | 2008-10-08 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients | |
| P478 | volume | 74 |
| Q37399705 | Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study |
| Q90609867 | Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial |
| Q36711673 | Challenges and opportunities for stem cell therapy in patients with chronic kidney disease |
| Q98895737 | Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency |
| Q90483253 | Circulating levels of CD34+ cells predict long-term cardiovascular outcomes in patients on maintenance hemodialysis |
| Q51063637 | Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+ cells in the ischaemic microcirculation |
| Q33633882 | Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis |
| Q38843000 | Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes. |
| Q83469418 | Critical confounders in the prognostic role of cellular biomarkers |
| Q36055443 | Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. |
| Q37590777 | Deficiency of Endothelial Progenitor Cells Associates with Graft Thrombosis in Patients Undergoing Endovascular Therapy of Dysfunctional Dialysis Grafts |
| Q40279810 | Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients. |
| Q36636749 | Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients |
| Q49253203 | Endothelial Progenitor Cells and Vascular Health in Dialysis Patients. |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q51260780 | High-density lipoprotein cholesterol affects early endothelial progenitor cell number and endothelial function in obese women |
| Q37766238 | Mesenchymal stem cell therapy for chronic renal failure |
| Q33610314 | Mobilization of CD34+-progenitor cells in patients with severe trauma |
| Q36721569 | Mobilization of Endothelial Progenitor Cells Following Creation of Arteriovenous Access in Patients with End-Stage Renal Disease. |
| Q33807117 | The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access |
Search more.